Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
30.07. | Vinay Prasad departs FDA amid conservative criticism, controversy over Sarepta gene therapy | ||
29.07. | In BTK clash, Lilly upstart Jaypirca measures up to warhorse Imbruvica | ||
29.07. | AstraZeneca proposes US price cut options as CEO Pascal Soriot sides with global 'rebalancing of pricing' | ||
29.07. | Publicis Health picks up p-value medical comms group | ||
29.07. | Trump's pharmaceutical tariffs materialize at last in new US-EU trade deal | ||
29.07. | Novo Nordisk names new CEO as the obesity drugmaker cuts sales, profit outlook | ||
29.07. | AbbVie, Gilead and GSK back World Hepatitis Day, seeking to tackle stigma to drive elimination | ||
29.07. | Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 | ||
28.07. | Eyeing commercial ADC capacity, injectables specialist Simtra snaps up land for Indiana expansion | ||
28.07. | Chiesi, Viatris among collaborators on BIO's latest BBC-produced video series | ||
28.07. | With RFK Jr. reportedly weighing preventative services panel revamp, HIV PrEP drugmakers could be at risk: analysts | ||
28.07. | Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs | ||
28.07. | Another FDA mini-pause for Bayer's menopause candidate? | ||
28.07. | FDA launches probe into new Elevidys death as Sarepta, Roche stress gene therapy not at fault | ||
28.07. | At odds with largest shareholder, Bavarian Nordic agrees to $3B buyout by Nordic and Permira | ||
25.07. | Labcorp sticks up for stem cell donations by joining Gift of Life 'Hero Gum' campaign | ||
25.07. | Doctored data, protest from trial observers: Lawsuit points to alleged misconduct at Amgen-bought biotech | ||
25.07. | Sun Pharma, Taro agree to $200M settlement in generics price-fixing litigation | ||
25.07. | Europe's CHMP gives thumbs-up to Lilly's Kisunla and Gilead's long-acting PrEP drug Yeytuo | ||
25.07. | GSK goes for gold in RSV, presenting TV special on senior athletes to raise awareness | ||
25.07. | Roche won't throw in the towel after DMD gene therapy Elevidys' rebuff in Europe | ||
25.07. | Fierce Pharma Asia-Moderna's scrapped Japanese plant; Rexulti's adcomm setback; Pfizer's option in 3SBio | ||
24.07. | FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report | ||
24.07. | Sanofi lends support to 'Dismissed' film about 5 women's experiences with hemophilia | ||
24.07. | Roche CEO weighs direct-to-consumer drug sales to ease US drug pricing woes, cut out middlemen |